BMC Joins the Age-Friendly Health System Community

To better support older adults and improve their health outcomes, health systems must put in place comprehensive, coordinated evidenced-based models that better deliver care to the growing aging population.

In September 2018, BMC joined John A. Hartford Foundation-Institute for Healthcare Improvement’s (IHI) Age-Friendly Health System Community in spreading age-friendly care with the goal of reaching 1,000 US hospitals and 1,000 medical practices by December 2020.

BMC is working towards a comprehensive approach to implementing best practices under the 4Ms (What Matters, Medication, Mentation, and Mobility) for each patient 65+ admitted to the hospital.

BMC is well on its way to becoming an Age-Friendly Health System!

Success of New Hyperglycemia Crisis Management Guideline

In AY2018 the Endocrine Subcommittee of the Pharmacy and Therapeutics Committee rolled out changes to the longstanding BMC Hyperglycemic Crisis Management Guideline, which had been in use for more than a decade.  A QI project done the prior year had shown higher rates of hypoglycemia (blood glucose (BG) <70) in patients after up-titration of the insulin infusion drip, in particular to doses of >0.14 unit/kg/hour of insulin.  These patients had a 3-fold higher rate of hypoglycemia, and in 60% of patients treated at this dose needed to have the drip stopped to prevent hypoglycemia (Figure 1).

Led by Dr. Sara Alexanian the Director of Inpatient Diabetes Program and Quality Leader in the Section of Endocrinology, a multidisciplinary group including en

Figure 1: percentage of patients experiencing hypoglycemia or having insulin drip prematurely stopped to prevent hypoglycemia on prior protocol.

docrine, pharmacy, nursing and IT came together to create an updated guideline.  The process included reviewing  primary literature supporting current hyperglycemic crisis management, review of national standards as well as protocols at outside institutions.  Based on this review a new guideline was developed.  Major changes included:

  1. Removal of default increases in the insulin infusion rate, and
  2. An updated insulin titration algorithm based on solid published evidence.

Subsequently there were several months of ED and ICU nursing education, including - in-services by endocrine and pharmacy, as well as a required Health Stream course.   The new guideline was rolled out in September 2019.

Three months after the release of the new guideline, a chart review was done on the 40 patients who were treated with the new algorithm compared to 35 patients on the prior protocol. There was a 60% reduction in hypoglycemia (26% on the prior protocol down to 10% on the new protocol, Table 1).  Furthermore the total episodes of hypoglycemia decreased with the new protocol, as did the number of times the drip needed to be stopped to prevent hypoglycemia.  Further analysis showed that despite the lower rates of hypoglycemia, there was no significant increase in the time to DKA resolution.

The multidisciplinary  workgroup continues to engage with nursing to improve the guideline.  Based on feedback, new changes include making minor adjustments to the insulin titration algorithm and making the transition to dextrose-containing fluids a default in the order set to ease nursing work-flow.  Furthermore, when substantial discrepancies occur between the ED and ICU weights, the nurse will be prompted to adjust the infusion dose appropriately for weight obtained on admission to the ICU. These changes are expected to go live in the fall 2019 with the hope of reducing hypoglycemic events further!

Table 1: Hypoglycemia with old and new protocols

BMC Quality Goals for Fiscal Year 2020 (FY 20)

Reducing Preventable Harm Index (PHI)

PHI is comprised of the 4 major Hospital Acquired Infections (HAIs) with a goal of 1.0 (YTD 0.84):

  • Catheter associated urinary tract infection (CAUTI),
  • Central Line Associated Bloodstream Infections (CLASBI)
  • Hospital acquired Clostridium difficile infections (CDIFF) and
  • Methacillin-Resistant Staph aureus bacteremia

The PHI also contains several perioperative/periprocedural complications and “never events” such as falls, pressure ulcers, and iatrogenic pneumothorax. The post-procedural complications followed most closely in internal medicine are venous thromboembolic events, hemorrhage/hematoma and development of acute kidney injury.

This year marks a major change in BMC’s approach to the monitoring and goal setting for HAIs .  We are shifting from rates and standardized infection ratios to simply following counts as we try to “chase zero” with the goal of zero events for each floor team. Following infection counts will allow us to assess and respond more quickly as an organization. Goal counts are in the table below.

If your team is following a patient who develops an HAI, please respond to the nurse manager’s request to meet to assist in the preparation of a preventability analysis.

Reducing Mortality

  • BMC’s O/E (Observed to Expected) mortality for FY2019 was 0.79 below the goal of <0.84.
  • BMC’s O/E Mortality Goal for FY2020 is 0.77 which places BMC in the top 25th percentile nationally in mortality compared to other academic medical centers.
  • What can I do?
  • Capture severity of illness by documenting all significant conditions in the H&P.
  • Engage Serious Illness Support Services for patients who have been identified as being at high risk of mortality in the next 6 months for discussions on advance care planning.
  • Refer BMC patients who are Comfort Measures Only patients for inpatient hospice screening.

BMC Physician Quality Leaders

In July 2016, BMC reorganized the Physician Quality Leaders, funding fewer quality leaders but giving each more responsibility and time to actually get things done.  They report to Dr. James Moses, BMC Chief Quality Officer, and address patient safety events as well as promote hospital quality initiatives.  They are also tasked specifically to work with residents and help mentor resident projects and ideas!!  Faculty and house staff, please reach out to the physician Quality Leader or the Medical Directors in your area of interest.  The current physician Quality Leaders are:

  • Chris Andry, PhD — Lab and Pathology
  • Willie Baker, MD — Emergency Medicine
  • Glenn Barest, MD — Radiology
  • Lisa Caruso, MD, MPH — Medicine (including Family Medicine, Neurology, Psychiatry, and all subspecialties)
  • Elizabeth Hutton, MD—Pediatrics
  • Ron Iverson, MD, MPH — Obstetrics/Gynecology
  • David McAneny, MD — Surgery (including all subspecialties)
  • James Murphy, MD — Critical Care (MICU, SICU, CCU), Medical Director of Inpatient Quality
  • Lauren Nentwich, MD — Emergency Medicine
  • Susan O’Horo, MD — Interventional Radiology
  • Susannah Rowe, MD, MPH — Ophthalmology

Angelique Harris, PhD, New Director of Faculty Development & Diversity

We are delighted to announce that Angelique Harris, PhD will begin as our new Director of Faculty Development and Diversity in the Department of Medicine, and Director of Faculty Development for the BU Medical Campus, starting on Tuesday, November 12th. She joins our faculty, having previously served as an Associate Professor of Sociology with tenure at Marquette University in Milwaukee, WI.

Originally from Mattapan, MA, Dr. Harris received her BA in socialpsychology and her MA in Applied Sociology from the University of Massachusetts, Boston. She later attended the City University of New York (CUNY), where she received her MA in Sociology from Queens College. She received her MPhil, and later her PhD in Sociology, with a focus in Medical Sociology, from the Graduate Center. Dr. Harris has taught as an adjunct professor at Hunter College, City College, and the College of New Rochelle’s South Bronx and Harlem campuses before working as an assistant professor of sociology at California State University, Fullerton and then later, Marquette University. While at Marquette, Dr. Harris developed the Culture, Health and Illness minor, and served as the Director of the Gender and Sexualities Studies Program and the Founding Director of the Center for Gender and Sexualities Studies, where she conducted trainings and workshops to promote faculty development and support equity and inclusion in and out of the classroom. Her research and teaching examine health, wellness, and belonging, as well as social problems and activism within marginalized communities.

We are beyond thrilled that she will be bringing her expertise and experience in faculty development, curriculum design, diversity and inclusion work, and teaching to the Department of Medicine and BU Medical Campus. Please join us in welcoming Dr. Harris!

Geriatrics Patient Tea Party

Our geriatrics patients really know how to have a good time!

The Geriatrics Section hosted their 2nd Patient Tea Party for on November 1st in the Geriatrics clinic on Shapiro 9.

About 20-25 patients, many of them 95-100 years old, and family members mingled with Geriatric physicians, nurses, and support staff. We were very proud to host a gathering with our community where everyone could share stories and celebrate good health . With the help of our team we were able to host a great afternoon filled with happiness, laughter & of course delicious sweets!

 

 

David Felson Awarded NIH Grant to Study Osteoarthritis

David Felson, MD, MPH, professor of medicine and epidemiology at Boston University Schools of Medicine and Public Health, was awarded a National Institutes of Health (NIH) P30 Center Grant.

As a member of the section of Rheumatology and the Boston University Core Center for Clinical Research, Dr. Felson's five-year $3.6 million award will provide broad clinical research methods expertise to a large multidisciplinary group of investigators whose research focuses on osteoarthritis and gout with a secondary emphasis on scleroderma, spondyloarthritis, osteoporosis and musculoskeletal pain.

The group, which includes persons with backgrounds in rheumatology, physical therapy, epidemiology, biostatistics and behavioral science, meets weekly to critically review research projects and serves a broad research community with which it actively engages. It has been successful in publishing influential papers on the diseases of focus and in training many of the clinical research faculty in the US and internationally.

Read More

2019 Evans Clinician Designees

The Evans Clinician Designation was established in 2017 to recognize and celebrate outstanding clinicians who possess clinical skills, attributes and professionalism that define excellence and to establish a home for such individuals to share experiences and grow their membership.

The following faculty have been designated as Evans Clinicians at the 2019 Evans Research Days:

Gary Balady, MD
Andrea Havasi, MD
Hasmeena Kathuria, MD
Eugene Kissin, MD
Adam Lerner, MD
Christine Phillips, MD
Rachel Simmons, MD

These faculty join previous designees as lifelong members of an expanding group of recognized clinicians who will define the role of the group over time.  Membership is meant to be honorific but not exclusive and is displayed on a special name tag.

Evans Research Days- Oct 3 & 4, 2019

 

View Photos

 

The 34th Annual Evans Department of Medicine Research Days celebrated and showcased the research activities of the department's faculty, trainees and researchers. This year's event featured the 2nd year of the Poster Blitz, 24 3-minute oral presentations of some of this year's most exciting submissions. The poster session featured 97 presentations, a record high for the event, and included digital poster displays in the newly remodeled entry lounge to the Hiebert Ball Room.

The Gala reception celebrated trainee winners of the Oral Presentations and Poster Session, and honored faculty recipients of the department's annual awards. This year's event saw the inaugural ARC Leadership Award presented by the Evans Center for Interdisciplinary Biomedical research and the inaugural David Aaron Freed award in memory of Aaron's legacy of compassion and excellence.

Thank you to all who helped make this year's event so special!

Award Winners

Evans Center IBR Research
Collaborator of the Year Award
Rhoda Au, PhD – Anatomy & Neurobiology
Inaugural ARC Leadership Award
Lindsay Farrer, PhD – Biomedical Genetics
Clinical Innovation Award
Palliative Medicine UnitSandhya D. Rao, MD -Team Lead
Henri Lee, MD
Perla Macip-Rodriguez, MD
Alexandra Dobie, LICSW
Jessica Knight, FNP-C, ACHPN
Amy L Cann, BS
Clinical Excellence Award
Won M. Lee, MD —Geriatrics
Junior Faculty Mentoring Award
Shayna Sarosiek MD —Hematology and
Medical Oncology
Jessica L Fetterman, PhD —Vascular Biology
Research Mentoring Award
Vipul C. Chitalia, MD, PhD –Nephrology
Citizenship Award
Thomas Ostrander, MD — General Internal Medicine
Gustavo Mostoslavsky, MD, PhD— Gastroenterology
 Clinical Quality Improvement Team Award
Antibiotic Stewardship TeamTamar F. Barlam MD – Team Lead
Karrine Brade PharmD – Co-Lead
Excellence in Educational Scholarship Mentoring
Catherine A. Rich, MD — General Internal Medicine
Special Recognition Teaching Award
Gopal Yadavalli, MD — Infectious Diseases
Inaugural David Aaron Freed Award
John Farrell — Biomedical Genetics
Most Abstract Submissions
Center for Regenerative Medicine (CReM)

Clinical Oral Presentation
1st Place: Maura Walker
2nd Place: Magdalena Buczek
3rd Place:  Simeon Kimmel
Basic Research Oral Presentation
1st Place:  Fatima Rizvi
2nd Place:  Jason Nasse
3rd Place:  Elissa Everton
 Clinical Poster Winners
1st Place: Mengjie Yuan
2nd Place: Feven Ataklte
3rd Place: Erika Crable
Basic Research Poster Winners
1st Place: Kristine Abo
2nd Place: Anukul Shenoy
3rd Place: Ayumu Osaki